Clinical Trial Update: INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors [Phase 1]

View source ↗

Summary

A Phase 1 trial of INCB106385, alone or with immunotherapy, in advanced solid tumors has completed. The study includes multiple indications such as ovarian canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Castration-resistant Prostate Cancer
• Colorectal Cancer
• Gastric Cancer
• Non-small Cell Lung Cancer
• Ovarian Cancer
• Squamous Cell Carcinoma of the Head and Neck
• Triple-negative Breast Cancer

Drugs mentioned

• INCB106385

Snippet

Sponsor: Incyte Corporation | Conditions: Ovarian Cancer, Bladder Cancer | Phase 1 | Status: COMPLETED